(Q36342389)

13 August 2017

1 reference

title

Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions (English)

1 reference

chronic renal insufficiency

13 August 2017

1 reference

1 reference

Anthony E Zimmermann

1

1 reference

13 August 2017

Thomas Pizzoferrato

2

1 reference

13 August 2017

John Bedford

3

1 reference

13 August 2017

Anne Morris

4

1 reference

13 August 2017

Robert Hoffman

5

1 reference

13 August 2017

Gregory Braden

6

1 reference

13 August 2017

language of work or name

English

0 references

publication date

8 December 2005

1 reference

Clinical Infectious Diseases

13 August 2017

1 reference

13 August 2017

42

1 reference

13 August 2017

2

1 reference

13 August 2017

283-290

1 reference

Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion

13 August 2017

1 reference

Cidofovir-induced end-stage renal failure

21 January 2018

1 reference

The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial

21 January 2018

1 reference

Frequency of urolithiasis in individuals seropositive for human immunodeficiency virus treated with indinavir is higher than previously assumed

21 January 2018

1 reference

Renal lesions in HIV-1-positive patient treated with tenofovir

21 January 2018

1 reference

Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity.

21 January 2018

1 reference

Fanconi syndrome and acute renal failure in a patient treated with tenofovir: a call for caution

21 January 2018

1 reference

21 January 2018

1 reference

Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases

21 January 2018

1 reference

21 January 2018

1 reference

Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome

21 January 2018

1 reference

Fanconi syndrome and renal failure induced by tenofovir: a first case report

21 January 2018

1 reference

Drug-induced Fanconi's syndrome.

21 January 2018

1 reference

Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure

21 January 2018

1 reference

Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs

21 January 2018

1 reference

Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study

21 January 2018

1 reference

Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex.

21 January 2018

1 reference

Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis

21 January 2018

1 reference

Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro.

21 January 2018

1 reference

Atazanavir enhances saquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimen

21 January 2018

1 reference

Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/499048

1 reference

13 August 2017

1 reference